{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:52:20Z","timestamp":1789523540690,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA018934"],"award-info":[{"award-number":["R01AA018934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24AA022002"],"award-info":[{"award-number":["U24AA022002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI34993"],"award-info":[{"award-number":["U01AI34993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI34994"],"award-info":[{"award-number":["U01AI34994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cct.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T17:46:35Z","timestamp":1497980795000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-3754","authenticated-orcid":false,"given":"Robert L.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-1802","authenticated-orcid":false,"given":"Kathleen","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Brumback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobeen","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardge","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2017.06.012_bb0005","unstructured":"Centers for Disease Control and Prevention. HIV Among Women. http:\/\/www.cdc.gov\/hiv\/group\/gender\/women\/. Published 2016. Accessed July 24, 2016."},{"key":"10.1016\/j.cct.2017.06.012_bb0010","doi-asserted-by":"crossref","first-page":"h4238","DOI":"10.1136\/bmj.h4238","article-title":"Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies","volume":"351","author":"Cao","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.cct.2017.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cct.2017.06.012_bb0020","first-page":"479","article-title":"The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review","volume":"41","author":"Kelso","year":"2015","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.cct.2017.06.012_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS Lond. Engl."},{"issue":"9939","key":"10.1016\/j.cct.2017.06.012_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet Lond. Engl."},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2017.06.012_bb0035","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciq047","article-title":"Challenges and successes in linking HIV-infected women to care in the United States","volume":"52","author":"Aziz","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cct.2017.06.012_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/apc.2014.0158","article-title":"Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina","volume":"29","author":"Chakraborty","year":"2015","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"10.1016\/j.cct.2017.06.012_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acer.12975","article-title":"Characterizing the association between alcohol and HIV virologic failure in a military cohort on antiretroviral therapy","volume":"40","author":"Deiss","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.cct.2017.06.012_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11904-010-0060-6","article-title":"Alcohol and HIV disease progression: weighing the evidence","volume":"7","author":"Hahn","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"5","key":"10.1016\/j.cct.2017.06.012_bb0055","doi-asserted-by":"crossref","first-page":"e0125088","DOI":"10.1371\/journal.pone.0125088","article-title":"Understanding the impact of hazardous and harmful use of alcohol and\/or other drugs on ARV adherence and disease progression","volume":"10","author":"Kader","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cct.2017.06.012_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10461-015-1025-y","article-title":"Alcohol-related diagnoses and all-cause hospitalization among HIV-infected and uninfected patients: a longitudinal analysis of United States veterans from 1997 to 2011","volume":"20","author":"Rentsch","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2017.06.012_bb0065","author":"National Institute on Alcohol Abuse and Alcoholism"},{"issue":"5","key":"10.1016\/j.cct.2017.06.012_bb0070","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10461-012-0270-6","article-title":"Alcohol consumption trajectory patterns in adult women with HIV infection","volume":"17","author":"Cook","year":"2013","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.cct.2017.06.012_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10461-006-9159-6","article-title":"Alcohol consumption, ART usage and high-risk sex among women infected with HIV","volume":"11","author":"Theall","year":"2007","journal-title":"AIDS Behav."},{"issue":"18","key":"10.1016\/j.cct.2017.06.012_bb0080","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cct.2017.06.012_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2017.06.012_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1530-0277.2007.00545.x","article-title":"Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment","volume":"32","author":"Tidey","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.cct.2017.06.012_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12889-016-2928-x","article-title":"Perceived benefits and negative consequences of alcohol consumption in women living with HIV: a qualitative study","volume":"16","author":"Cook","year":"2016","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.cct.2017.06.012_bb0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"7","key":"10.1016\/j.cct.2017.06.012_bb0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/apc.2011.0447","article-title":"Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder","volume":"26","author":"Badiee","year":"2012","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"10.1016\/j.cct.2017.06.012_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11606-009-1164-9","article-title":"Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men","volume":"25","author":"Cook","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2017.06.012_bb0115","series-title":"Measuring Alcohol Consumption: Psychosocial and Biological Methods","first-page":"41","article-title":"Timeline Follow-back: a technique for assessing self-reported ethanol consumption","author":"Sobell","year":"1992"},{"issue":"6","key":"10.1016\/j.cct.2017.06.012_bb0120","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"Suppl. 20","key":"10.1016\/j.cct.2017.06.012_bb0125","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.cct.2017.06.012_bb0130","author":"Miller"},{"issue":"4","key":"10.1016\/j.cct.2017.06.012_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/alcalc\/agl027","article-title":"PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients","volume":"41","author":"Aradottir","year":"2006","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.cct.2017.06.012_bb0140","author":"Pettinati"},{"key":"10.1016\/j.cct.2017.06.012_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","volume":"15","author":"Johnson","year":"2005","journal-title":"J. Stud. Alcohol Suppl."},{"issue":"12","key":"10.1016\/j.cct.2017.06.012_bb0150","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/acer.12197","article-title":"The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies","volume":"37","author":"Litten","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.cct.2017.06.012_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/QAI.0000000000000679","article-title":"Brief intervention decreases drinking frequency in HIV-infected, heavy drinking women: results of a randomized controlled trial","volume":"70","author":"Chander","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417300162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417300162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T13:35:58Z","timestamp":1602336958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714417300162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":31,"alternative-id":["S1551714417300162"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2017.06.012","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}